Conclusion This study showed combination chemotherapy led to a decreasing trend of MoM of serum AMH especially at 12 months after treatment, but the drop became static at 24 months.
← all excerpts
Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
3
—
—
The sentences
The trend of decline from the baseline was marginally significant in patients with combination chemotherapy, but the drop was only significant at 12 months ( Z = −2.69, p = 0.007) but not at 24 months ( Z = −1.90; p = 0.058).
We showed a trend of decrease in those receiving combination chemotherapy, but it became static between 12 and 24 months and the live birth rate was not jeopardized by the chemotherapy.